Long before a needle touches the skin, your immune system may have already decided how it's going to respond. Hidden among the antibodies circulating in a person’s blood could be signs of whether an upcoming vaccine will trigger a powerful defense or a comparatively weak response.
Vaccines protect most people from severe disease, but their effectiveness is not identical in everyone. A new study published in Cell Press Blue suggests researchers may be able to anticipate some of that variation using pre-vaccination blood samples and artificial intelligence.
The findings could eventually help doctors identify people who may benefit from extra doses, closer monitoring, or other protective measures.
“What our study found is that certain biomarkers, when analyzed with AI, can predict who is likely to respond well to a vaccine, even before they receive it. This suggests that some people may be more immune-ready than others,” said study lead Joshua LaBaer in a press release.
Preexisting Antibodies May Predict Vaccine Response
Researchers examined blood samples from more than 4,000 people, measuring antibodies that reacted to 185 antigens. These immune targets included components of familiar viruses and bacteria, along with markers connected to autoimmune diseases.
The team compared antibody patterns recorded before and after COVID-19 vaccination. They discovered that elevated levels of several preexisting antibodies were associated with stronger responses to the vaccine, including common microbes like Staphylococcus aureus, respiratory syncytial virus (RSV), and human respirovirus 3.
Explore All OptionsThe scientists suggest these are “sentinel” antibodies because they are not necessarily helping the body attack the vaccine’s intended target. Instead, they may serve as signals of how prepared the antibody-producing portion of the immune system is to spring into action.
Read More: COVID-19 Is Spreading Again as a Summer Wave Grows Across the U.S.
Why Vaccine Protection Varies Between People
Scientists typically assess vaccine response after a vaccine, measuring the antibodies generated against a particular target. This study reversed the question by asking whether someone’s existing immune landscape could forecast their reaction before vaccination.
Age, biological sex, genetics, previous infections, and underlying medical conditions can all influence vaccine responses. Immunosuppressive medications or illnesses can also limit the immune system’s ability to react. Yet broad health categories do not tell the entire story.
Several immunosuppressed groups in the study were most likely to produce weaker responses, but some immunosuppressed participants still responded strongly. Meanwhile, approximately 5 to 6 percent of otherwise healthy participants had weak responses. That inconsistency suggests immune readiness cannot always be determined from a person’s diagnosis or general health status alone.
How AI Could Help Personalize Future Vaccines
Rather than relying on one antibody, the researchers trained a deep-learning model to examine patterns across the entire panel. By combining numerous measurements into a larger immune fingerprint, the system could distinguish stronger vaccine responders from weaker ones.
This is where AI offers a particular advantage. Biological datasets can contain millions of overlapping data points, making meaningful connections difficult for humans to spot. Machine-learning models can search that complexity for subtle combinations that carry predictive value.
The results suggest researchers may learn more by viewing immunity as a landscape shaped by many past encounters with microbes, rather than checking for antibodies against only one pathogen.
Although the study focused on COVID-19 vaccination, the method could have wider applications. With further validation, sentinel antibody profiles might support vaccine development and help clinicians recognize patients who need additional doses, follow-up testing, or alternative protection.
The future of vaccination may therefore involve more than choosing the right shot — it may also mean understanding the immune system receiving it.
This article is not offering medical advice and should be used for informational purposes only.
Read More: COVID-19 Excess Mortality Study Retracted Over Misinformation in Its Discussion
Article Sources
Our writers at Discovermagazine.com use peer-reviewed studies and high-quality sources for our articles, and our editors review for scientific accuracy and editorial standards. Review the sources used below for this article:
- This article references information from a study published in Cell Press Blue: Pre-vaccine sentinel antibodies predict blunted vaccine responses
